While N-MYC and TEM8 have established roles in promoting PCa progression, the underlying mechanism remains poorly understood; however, targeting the N-MYC/TEM8 pathway appears to be promising for treatment of PCa and TEM8 may be a useful indicator of treatment responses in patients with PCa [355]. Here, ANTXR1 is linked to posterior cortical atrophy.